MAL19991350ACRZPrescription (MAL-A)

COMBIVIR TABLET

Generic Molecule: Zidovudine 300 mg Tablet & Lamivudine 150 mg Tablet

ACTIVE & APPROVEDValid till: 26 Nov 2030
NPRA Official Regulatory Summary

COMBIVIR TABLET is a KKM-approved Prescription Medicine registered under MAL number MAL19991350ACRZ by GLAXOSMITHKLINE PHARMACEUTICAL SDN. BHD.. Its active ingredient is ZIDOVUDINE/AZIDOTHYMIDINE 300MG, LAMIVUDINE 150MG, manufactured by Delpharm Poznan Spolka Akcyjna.

Holder (PRH)
GLAXOSMITHKLINE PHARMACEUTICAL SDN. BHD.
Manufacturer
Delpharm Poznan Spolka Akcyjna
First Registered
26 Nov 2025
Validity
26 Nov 2030

Prescription Required (Schedule Poison)

Need a valid doctor's prescription renewal in Malaysia?

Consult Online Doctor (Telehealth)

Active Ingredients & Strength Formulation

2 Components
Active Substance / MoleculeDeclared Strength / DosageGeneric Directory
ZIDOVUDINE/AZIDOTHYMIDINE300MGFind Brands
LAMIVUDINE150MGFind Brands
Dosage values indicate declared active concentration per unit dose as registered with NPRA Malaysia.

Malaysian KKM Security Hologram Verification

FarmaChecker & Meditag™

By Malaysian Ministry of Health (KKM) regulation, all genuine registered pharmaceuticals, health supplements (MAL-N), and traditional products (MAL-T) distributed in Malaysia must feature an official tamper-evident security hologram sticker on the physical packaging.

1. Visual Tilt Check

Tilt the box under light to view the micro-engraved KKM coat of arms and multi-layer iridescent security patterns.

2. Match MAL Number

Ensure the printed MAL code matches MAL19991350ACRZ exactly on label and box.

3. FarmaChecker Scan

Scan using the official FarmaChecker app on iOS / Android to authenticate serial token with NPRA servers.

If the packaging lacks a security hologram or fails the FarmaChecker scan, do not consume and report to Cawangan Penguatkuasaan Farmasi (CPF KKM).
Frequently Asked Questions & Verification Details

Is COMBIVIR TABLET approved by KKM / NPRA?

Yes. COMBIVIR TABLET is actively registered with the National Pharmaceutical Regulatory Agency under official registration number MAL19991350ACRZ with current status PRODUCT APPROVED. Registration was filed by GLAXOSMITHKLINE PHARMACEUTICAL SDN. BHD..

What are the active ingredients of COMBIVIR TABLET?

The declared active therapeutic components are: ZIDOVUDINE/AZIDOTHYMIDINE 300MG, LAMIVUDINE 150MG. Always follow dosage recommendations prescribed by a certified doctor or licensed pharmacist.

What are the registered generic alternatives in Malaysia?

In Malaysia, there are 7 registered brand formulations containing identical active ingredients (Zidovudine). You can review them in the alternative brands section above or consult your community pharmacist for generic bioequivalent substitution.

Semakan status pendaftaran KKM / NPRA: COMBIVIR TABLET (MAL19991350ACRZ) | Pengganti ubat di Malaysia | Bahan aktif ubat & maklumat farmasi.